Close Menu
Home › Technology › Microarrays & Multiplexing

Microarrays & Multiplexing

News on microarrays, multiplexing, genotyping, cytogenetics, gene expression profiling in genetics, genomics, and molecular diagnostics.

Quotient Fiscal Q4 Revenues Grow 36 Percent

Product sales from OEM customers were up 28 percent, while product sales from direct customers and distributors increased 27 percent, and other revenues grew sharply.

Custom NanoString Assay Detects Bowel Cancer Subtypes, May Help Guide Therapies

Premium

The researchers have used nCounter, an FDA-cleared platform from NanoString Technologies, to develop their gene expression assay for subtype classification.

Agendia, Imegen Ink Distribution Deal for Breast Cancer Tests in Spain, Portugal

MammaPrint classifies patients as either high risk or low risk of recurrence over a 10-year period while BluePrint classifies patients by breast cancer subtype.

NanoString Revenues Climb 18 Percent in Q1

The company reported total revenues of $27.7 million, with growth in its consumables business but a drop in instrument revenues from the prior year's first quarter.

Almac Assay's Ability to Stratify Esophageal Cancer Patients Demonstrated by UK Researchers

Premium

The test relies on a signature that Almac developed for stratifying breast cancer patients, but which, as the researchers showed, can be used in other cancers as well.

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb LLC.  All Rights Reserved.